Evidence map›Paper›PMID 41226600›Full record

ArticleInternational journal of molecular sciences2025

Circulating and Urinary CCL20 in Human Kidney Disease.

Noelia Molina-Cazallas, Diego García-Ayuso, Beatriz Fernández-Fernández, Laura Rodríguez-Osorio, Jinny Sanchez-Rodriguez, María Vanessa Pérez-Gómez, Alberto Ortiz, Adrián M Ramos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Noelia Molina-CazallasLaboratorio de Nefrología e Hipertensión, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain.ORCID 0009-0008-3372-0545
Diego García-AyusoLaboratorio de Nefrología e Hipertensión, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain.
Beatriz Fernández-FernándezRICORS2040-Renal, Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Laura Rodríguez-OsorioServicio de Nefrología, Hospital Universitario General de Villalba, 28400 Madrid, Spain.
Jinny Sanchez-RodriguezRICORS2040-Renal, Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
María Vanessa Pérez-GómezRICORS2040-Renal, Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Alberto OrtizLaboratorio de Nefrología e Hipertensión, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain.ORCID 0000-0002-9805-9523
Adrián M RamosLaboratorio de Nefrología e Hipertensión, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain.

Funding

Comunidad de Madrid en Biomedicina P2022/BMD-7223, CIFRA_COR-CM.COST Action PERMEDIK CA21165ERAPERMED2022-248 SIGNAL (AC22/00028) ;ERA-PerMed-JTC2022 SPAREKID AC22/00027HORIZON-HLTH-2023-CARE-04 Programme HORIZON, DG/Agency HADEAInstituto de Salud Carlos III PI20/00744, PI21/00251, PI21/01453, PI22/00469, PI22/00050, PI22/01168, PI23/00627Instituto de Salud Carlos III RICORS2040-renal (RD21/0005/0001, RD24/0004/0001)KitNewCare 101137054PICKED Project 101168626PREVENTCKD Consortium 101101220SPACKDc PMP21/00109
6 · The paper itself

Abstract

CC motif chemokine ligand 20 (CCL20), a chemokine involved in immune cell migration through its receptor CCR6, has been implicated in kidney inflammation in crescentic glomerulonephritis and acute kidney injury. However, clinical information for other kidney diseases is scarce. We have analysed CCL20 levels in plasma and urine from patients with diabetic kidney disease (DKD,

Indexed as

Chemokine CCL20Diabetic NephropathiesAdultAgedBiomarkersFemaleHumansKidneyMaleMiddle AgedBiomarkersCCL20 protein, humanChemokine CCL20autosomal dominant polycystic kidney diseaseCC motif chemokine ligand 20 (CCL20)chronic kidney diseaseclinical outcomesdiabetic kidney diseaseobservational study

Identifiers

PMID41226600
PMCPMC12610836

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.